Aesthetic Medical International Holdings Group Ltd.
Aesthetic Medical International Holdings Group Ltd. is a prominent player in the healthcare industry, particularly in the field of aesthetic medical services. The company's primary function is to provide a wide array of beauty and cosmetic enhancement solutions, including aesthetic surgery, minimally invasive procedures, and dermatology services. These offerings cater to a growing demand for personalized beauty treatments and wellness solutions across various demographics. Notably, Aesthetic Medical International operates extensively in fast-growing markets, particularly within Asia, where the beauty and wellness industry is experiencing robust expansion. The company's network of clinics and specialized centers are strategically located to leverage the increasing consumer interest in aesthetic services. By employing state-of-the-art technology and skilled professionals, the group aims to deliver high-quality, safe, and effective treatments. In the financial market, Aesthetic Medical International Holdings Group Ltd. represents a significant enterprise within the healthcare sector, reflecting broader trends in consumer health, self-care, and wellness. Its role suggests an evolving perspective on beauty and medical services as people increasingly seek treatments that enhance their appearance and confidence.
$0.01
+$0.00 (+0.00%)
Price from 2 days ago
Operating margin is thin at 0.72%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 4.3% YoY. The question is whether this is cyclical or a structural shift.
Free cash flow declined 139% versus the prior year, cash generation momentum has weakened. Negative free cash flow of -¥19M. The business is consuming cash, not generating it.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
¥723M
▼ -4.3% YoY
Net Income (TTM)
-¥54M
▼ -115.6% YoY
Op. Margin
0.72%
▲ +1.3pp YoY
ROIC
1.76%
▲ +3.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-¥19M
▼ -139.3% YoY
Op. Cash Flow (TTM)
-¥12M
▼ -115.3% YoY
Net Debt
¥220M
Cash & Equiv.
¥60M
3Y CAGR: +2.6%
Continue Research
Is Aesthetic Medical International Holdings Group (PAIYY) overvalued?
Aesthetic Medical International Holdings Group (PAIYY)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Aesthetic Medical International Holdings Group scores 23/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from company filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
Is Aesthetic Medical International Holdings Group a high-quality business?+
Aesthetic Medical International Holdings Group scores 23 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 0.7% operating margin and a 1.8% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from company filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is Aesthetic Medical International Holdings Group a good stock to buy right now?+
That depends on valuation and quality together, not either alone. you should weigh PAIYY's valuation and scores 23/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from company filings, not investment advice.
Related stocks: Medical Care Facilities
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.